Skip to content
Home/Companies/Consumer/Alliance Pharma

Alliance Pharma

Consumer·France·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Alliance Pharma?

Alliance Pharma is a French Consumer company, currently owned by Elyan Partners since 2025 and Edmond de Rothschild Private Equity (France).

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Edmond de Rothschild Private Equity (France)
Most recent investor
Edmond de Rothschild Private Equity (France)
PEARL Infrastructure Capital II SCA, RAIF · 2024 · Real Estate
3 ownership periods · full history below

Key facts

HQFrance
SectorConsumer

Ownership history

3 ownership periods · co-invest detected

Co-invest · 3 holders · 2025 · present
Elyan Partners
2025 · present(1yr) · ERES IV · 2021 · Buyout
Edmond de Rothschild Private Equity (France)
2025 · present(1yr) · PEARL Infrastructure Capital II SCA, RAIF · 2024 · Real Estate
Elyan Partners
2025 · present(1yr) · EDRPEO FCPR · 2021 · Evergreen

Questions

Who owns Alliance Pharma?

Alliance Pharma is currently owned by Elyan Partners and Edmond de Rothschild Private Equity (France), through PEARL Infrastructure Capital II SCA, RAIF, since 2025.

When did Elyan Partners and 1 other acquire Alliance Pharma?

Elyan Partners and 1 other acquired Alliance Pharma in 2025.

Who has owned Alliance Pharma over time?

Alliance Pharma has been through 3 private-equity ownership periods: Elyan Partners · via ERES IV · since 2025; Elyan Partners · via EDRPEO FCPR · since 2025; Edmond de Rothschild Private Equity (France) · via PEARL Infrastructure Capital II SCA, RAIF · since 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue